Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Crystal form B of ABT-888, preparation method and applications thereof

A technology of ABT-888 and crystal form, applied in organic chemical methods, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve the problems of high operation requirements, complicated preparation process, poor solubility, etc., and achieve low cost , simple operation, and the effect of improving solubility

Active Publication Date: 2015-12-09
CRYSTAL PHARMATECH CO LTD
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the two crystal forms, the solubility of crystal form 1 is relatively good, but crystal form 1 needs to react with the acid or diacid salt of ABT-888 with a base, and the crystal form 1 mixed with one or more than one solvent can be made by deprotonation reaction. ABT-888 is obtained by crystallization or recrystallization in the form of solid, semi-solid, wax or oil. The preparation process is relatively complicated and the requirements for operation are also high.
Although the preparation of crystal form 2 is relatively simple, it can be obtained by completely dissolving ABT-888 in methanol, then concentrating at 35°C, and drying to constant weight, but its solubility is poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystal form B of ABT-888, preparation method and applications thereof
  • Crystal form B of ABT-888, preparation method and applications thereof
  • Crystal form B of ABT-888, preparation method and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Dissolve 21.8 mg of the free base of the compound of formula I in 1.5 mL of methanol and volatilize at room temperature (25±1° C.) to obtain solid crystals, labeled as sample 1.

Embodiment 2

[0031] 20.7 mg of the free base of the compound of formula I was dissolved in 1.0 mL of methanol, and volatilized at room temperature (25±1° C.) to obtain solid crystals, labeled as sample 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a crystal form B of ABT-888, a preparation method and applications thereof, wherein the characteristic peaks exist in the X-ray powder diffraction spectrum (CuK[alpha] radiation) of the crystal form B when the 2[theta] value is 9.4+ / -0.2 DEG, 17.3+ / -0.2 DEG, and 22.8+ / -0.2 DEG. The preparation method comprises: dissolving ABT-888 free alkali in methanol, and naturally volatilizing at a room temperature to obtain the crystal form B. Compared with the existing crystal form, the crystal form B has characteristics of high solubility, simple preparation process and good stability, and provides important significance for improvement of treatment effects of metastatic breast cancer, colon cancer, metastatic melanoma and brain tumor and reduction of drug loading.

Description

technical field [0001] The present invention relates to crystal form B of 2-[(2R)-2-methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide and a preparation method thereof. Background technique [0002] 2-[(2R)-2-methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide (compound shown in formula I), also known as ABT-888 (veliparib), is manufactured by Abbott ( A new type of highly selective PARP inhibitor developed by Abbvie). In vivo and in vitro experiments have shown that ABT-888 has a significant inhibitory effect on PARP activity, and has achieved remarkable effects in the treatment of metastatic breast cancer, colon cancer, metastatic melanoma and brain tumors. At present, the combined application of ABT-888 and whole brain radiotherapy for the treatment of metastatic brain tumors has entered the phase I clinical stage, and the treatment of metastatic breast cancer, colon cancer and metastatic melanoma has also entered the phase II clinical stage, and it is used in combi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D403/04A61K31/4184A61P35/00
CPCC07B2200/13C07D403/04A61K31/4184
Inventor 陈敏华张炎锋刘凯张晓宇
Owner CRYSTAL PHARMATECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com